Chunke Chen
State Key Laboratory Of Respiratory Disease
Guangzhou, 510182, China
Guangzhou, 510182, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Robust cross-neutralizing antibody responses but variable cellular immunity following either Comirnaty and Spikevax JN.1-adapted mRNA vaccination in the elderly.
Journal: Vaccine
Published: December 12, 2025
Unveiling the epitope repertoires and protective roles of MERS-CoV-specific T cells in mice.
Journal: Cell reports
Published: July 21, 2025
Comparison of safety and immunogenicity in the elderly after receiving either Comirnaty or Spikevax monovalent XBB1.5 COVID-19 vaccine.
Journal: The Journal of infection
Published: July 17, 2024
Determination of T cell response against XBB variants in adults who received either monovalent wild-type inactivated whole virus or mRNA vaccine or bivalent WT/BA.4-5 COVID-19 mRNA vaccine as the additional booster.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: June 03, 2024
Mouse models susceptible to HCoV-229E and HCoV-NL63 and cross protection from challenge with SARS-CoV-2.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 18, 2023
Age-related seroprevalence trajectories of seasonal coronaviruses in children including neonates in Guangzhou, China.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: August 15, 2022
The N-Terminal Region of Middle East Respiratory Syndrome Coronavirus Accessory Protein 8b Is Essential for Enhanced Virulence of an Attenuated Murine Coronavirus.
Journal: Journal of virology
Published: November 24, 2021
Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID-19 vaccines in Hong Kong.
Journal: Respirology (Carlton, Vic.)
Published: August 21, 2021
Multi-platform omics analysis reveals molecular signature for COVID-19 pathogenesis, prognosis and drug target discovery.
Journal: Signal transduction and targeted therapy
Published: September 05, 2020
Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment.
Journal: Cell
Published: May 15, 2020
Kinetics of viral load and antibody response in relation to COVID-19 severity.
Journal: The Journal of clinical investigation
Published: April 02, 2020
Probing the nuclear import signal and nuclear transport molecular determinants of PRV ICP22.
Journal: Cell & bioscience
Published: August 04, 2015
Last Updated: 09/26/2026